Literature DB >> 15280465

Pulmonary collectins modulate strain-specific influenza a virus infection and host responses.

Samuel Hawgood1, Cynthia Brown, Jess Edmondson, Amber Stumbaugh, Lennell Allen, Jon Goerke, Howard Clark, Francis Poulain.   

Abstract

Collectins are secreted collagen-like lectins that bind, agglutinate, and neutralize influenza A virus (IAV) in vitro. Surfactant proteins A and D (SP-A and SP-D) are collectins expressed in the airway and alveolar epithelium and could have a role in the regulation of IAV infection in vivo. Previous studies have shown that binding of SP-D to IAV is dependent on the glycosylation of specific sites on the HA1 domain of hemagglutinin on the surface of IAV, while the binding of SP-A to the HA1 domain is dependent on the glycosylation of the carbohydrate recognition domain of SP-A. Here, using SP-A and SP-D gene-targeted mice on a common C57BL6 background, we report that viral replication and the host response as measured by weight loss, neutrophil influx into the lung, and local cytokine release are regulated by SP-D but not SP-A when the IAV is glycosylated at a specific site (N165) on the HA1 domain. SP-D does not protect against IAV infection with a strain lacking glycosylation at N165. With the exception of a small difference on day 2 after infection with X-79, we did not find any significant difference in viral load in SP-A(-/-) mice with either IAV strain, although small differences in the cytokine responses to IAV were detected in SP-A(-/-) mice. Mice deficient in both SP-A and SP-D responded to IAV similarly to mice deficient in SP-D alone. Since most strains of IAV currently circulating are glycosylated at N165, SP-D may play a role in protection from IAV infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15280465      PMCID: PMC479098          DOI: 10.1128/JVI.78.16.8565-8572.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice.

Authors:  S E Wert; M Yoshida; A M LeVine; M Ikegami; T Jones; G F Ross; J H Fisher; T R Korfhagen; J A Whitsett
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  Surfactant protein D enhances clearance of influenza A virus from the lung in vivo.

Authors:  A M LeVine; J A Whitsett; K L Hartshorn; E C Crouch; T R Korfhagen
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

3.  Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis.

Authors:  T Madan; U Kishore; M Singh; P Strong; E M Hussain; K B Reid; P U Sarma
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

4.  Changes in the hemagglutinin molecule of influenza type A (H3N2) virus associated with increased virulence for mice.

Authors:  C A Hartley; P C Reading; A C Ward; E M Anders
Journal:  Arch Virol       Date:  1997       Impact factor: 2.574

5.  Sequential targeted deficiency of SP-A and -D leads to progressive alveolar lipoproteinosis and emphysema.

Authors:  Samuel Hawgood; Matthias Ochs; Anja Jung; Jennifer Akiyama; Lennell Allen; Cindy Brown; Jess Edmondson; Stacey Levitt; Elaine Carlson; Anne Marie Gillespie; Angela Villar; Charles J Epstein; Francis R Poulain
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-11       Impact factor: 5.464

6.  Surfactant proteins A and D protect mice against pulmonary hypersensitivity induced by Aspergillus fumigatus antigens and allergens.

Authors:  T Madan; U Kishore; M Singh; P Strong; H Clark; E M Hussain; K B Reid; P U Sarma
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

7.  Complementation of pulmonary abnormalities in SP-D(-/-) mice with an SP-D/conglutinin fusion protein.

Authors:  Liqian Zhang; Kevan L Hartshorn; Erika C Crouch; Machiko Ikegami; Jeffrey A Whitsett
Journal:  J Biol Chem       Date:  2002-04-15       Impact factor: 5.157

8.  Surfactant protein-A--deficient mice display an exaggerated early inflammatory response to a beta-resistant strain of influenza A virus.

Authors:  Gordon Li; Jiyauddin Siddiqui; Michael Hendry; Jennifer Akiyama; Jess Edmondson; Cynthia Brown; Lennell Allen; Stacey Levitt; Francis Poulain; Samuel Hawgood
Journal:  Am J Respir Cell Mol Biol       Date:  2002-03       Impact factor: 6.914

9.  Absence of SP-A modulates innate and adaptive defense responses to pulmonary influenza infection.

Authors:  Ann Marie LeVine; Kevan Hartshorn; James Elliott; Jeffrey Whitsett; Thomas Korfhagen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-03       Impact factor: 5.464

10.  Pulmonary surfactant protein A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages.

Authors:  Alison A Beharka; Cecilia D Gaynor; Byoung K Kang; Dennis R Voelker; Francis X McCormack; Larry S Schlesinger
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

View more
  57 in total

Review 1.  Collectins and cationic antimicrobial peptides of the respiratory epithelia.

Authors:  B Grubor; D K Meyerholz; M R Ackermann
Journal:  Vet Pathol       Date:  2006-09       Impact factor: 2.221

2.  Mitogenic stimulation accelerates influenza-induced mortality by increasing susceptibility of alveolar type II cells to infection.

Authors:  Nikolaos M Nikolaidis; John G Noel; Lori B Pitstick; Jason C Gardner; Yasuaki Uehara; Huixing Wu; Atsushi Saito; Kara E Lewnard; Huan Liu; Mitchell R White; Kevan L Hartshorn; Francis X McCormack
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

3.  Role of surfactant proteins A and D in sepsis-induced acute kidney injury.

Authors:  Jiao Liu; Osama Abdel-Razek; Zhiyong Liu; Fengqi Hu; Qingshan Zhou; Robert N Cooney; Guirong Wang
Journal:  Shock       Date:  2015-01       Impact factor: 3.454

4.  Alveolar surfactant protein D content modulates bleomycin-induced lung injury.

Authors:  John Casey; Jennifer Kaplan; Elena N Atochina-Vasserman; Andrew J Gow; Helchem Kadire; Yaniv Tomer; James H Fisher; Samuel Hawgood; Rashmin C Savani; Michael F Beers
Journal:  Am J Respir Crit Care Med       Date:  2005-06-30       Impact factor: 21.405

5.  Increasing antiviral activity of surfactant protein d trimers by introducing residues from bovine serum collectins: dissociation of mannan-binding and antiviral activity.

Authors:  K L Hartshorn; M R White; K Smith; G Sorensen; Y Kuroki; U Holmskov; J Head; E C Crouch
Journal:  Scand J Immunol       Date:  2010-07       Impact factor: 3.487

6.  Introduction of N-linked glycans in the lectin domain of surfactant protein D: impact on interactions with influenza A viruses.

Authors:  Martin van Eijk; Laurie Bruinsma; Kevan L Hartshorn; Mitchell R White; Michael J Rynkiewicz; Barbara A Seaton; Wieger Hemrika; Roland A Romijn; Bas W van Balkom; Henk P Haagsman
Journal:  J Biol Chem       Date:  2011-04-13       Impact factor: 5.157

7.  Phosphatidylglycerol suppresses influenza A virus infection.

Authors:  Mari Numata; Pitchaimani Kandasamy; Yoji Nagashima; Janelle Posey; Kevan Hartshorn; David Woodland; Dennis R Voelker
Journal:  Am J Respir Cell Mol Biol       Date:  2011-11-03       Impact factor: 6.914

8.  Viral aggregating and opsonizing activity in collectin trimers.

Authors:  Kevan L Hartshorn; Mitchell R White; Tesfaldet Tecle; Grith Sorensen; Uffe Holmskov; Erika C Crouch
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-10-16       Impact factor: 5.464

9.  Mitogen-activated protein kinases and NFkappaB are involved in SP-A-enhanced responses of macrophages to mycobacteria.

Authors:  Joseph P Lopez; David J Vigerust; Virginia L Shepherd
Journal:  Respir Res       Date:  2009-07-01

10.  Loss of a single N-linked glycan from the hemagglutinin of influenza virus is associated with resistance to collectins and increased virulence in mice.

Authors:  Patrick C Reading; Danielle L Pickett; Michelle D Tate; Paul G Whitney; Emma R Job; Andrew G Brooks
Journal:  Respir Res       Date:  2009-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.